Aminoglycoside resistance in gram-positive cocci is generally due to synthesis of enzymes which modify the antibiotics (8) . As in gram-negative bacteria, the enzymes can be divided into three classes depending on the reaction catalyzed (phosphorylation or adenylylation of a hydroxyl group, acetylation of an amino group) and are named according to the site they modify on the antibiotic molecule (18) . The enzymes vary in their substrate ranges, which can be very broad (5) .
The modifying activities detected in enterococci to date constitute a subset of the staphylococcal enzymes: enzymes with identical site specificity were previously found in staphylococci (R. Leclercq, S. Dutka-Malen, A. Brisson-Noel, C. Molinas, E. Derlot, M. Arthur, and P. Courvalin, Rev. Infect. Dis., in press) ( Table 1) . Comparison of expression, function, and structure of several enzymes and of the corresponding plasmid genes showed that enzymes from gram-positive cocci with identical site specificities were very similar (10, 11) .
We have determined the nucleotide sequence of the structural genes for APH(3') (aminoglycoside phosphotransferase), ANT(6) (aminoglycoside nucleotidyltransferase), and the bifunctional enzyme APH(2")-AAC(6') (aminoglycoside acetyltransferase) from Enterococcus spp. (17, 30, 36) . Using intragenic probes, we studied by DNA-DNA hybridization the relationship between the resistance determinants encoding these enzymes in 1,000 clinical isolates of Enterococcus and Staphylococcus. We also included a probe specific for ANT(4') from Staphylococcus spp., an enzyme which, to our knowledge, has not yet been detected in enterococci. The results obtained indicated that there is a high degree of gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci and that, except for streptomycin, DNA probes constitute a valid approach for the detection of aminoglycoside resistance in these human pathogens.
MATERIALS AND METHODS
Bacterial strains and plasmids. Strains of Staphylococcus spp. and Enterococcus spp., approximately 500 of each, were collected in 24 French hospitals in 1985. The strains were selected for resistance to at least one of the aminoglycosides tested (Table 2) . Initial identification was based on colony and microscopic morphologies and coagulase testing. Coagulase-negative staphylococci were identified at the species level with API Staph-Indent kits (API System, La Balme-les-Grottes, France). The enterococci were identified by the absence of catalase; inability to produce gas; presence of Lancefield antigen group D; and growth on 40% bile, in 6.5% sodium chloride, in 0.1% methylene blue, and at pH 9.6. Species identification (15, 31) was based on the absence of reduction of potassium tellurite and tests for acid production from 50 carbohydrates in API 50 CH galleries (API System). The staphylococcal strains were screened for aminoglycoside resistance by the disk agar diffusion technique (Diagnostics Pasteur, Marnes-la-Coquette, France). Disks containing 500 ,ug of streptomycin, tobramycin, and gentamicin and 1,000 ,ug of kanamycin (Diagnostics Pasteur) were used to screen enterococci for high-level resistance to aminoglycosides. Enterococcus faecalis JH2-2 harboring plasmids pJH1 (ant6, aph3') (14) or pIP800 (aph2"-aac6') (10) and BM6217 (ant6, aph3', aph2"-aac6') (7); Staphylococcus aureus RN450 harboring plasmids pSH2 (aph3') (12), RN1956 (aph3') (12), pWA1 (aph3') (13), and pUB110 (ant4') (21); and S. aureus BM3002 (ant4') (23), RN450-Agr (aph2"-aac6') (11), PALM (aph2"-aac6') (24) , and 80CR5 containing TnJ545 (aph3') in the chromosome (9) were included as control strains. E. faecalis JH2-2 (20), S. aureus RN450 (29) and 209P, and 10 strains from our laboratory collection belonging to the species represented in this study were Preparation of DNA. Cells from 1.5 ml of an overnight broth culture were harvested, suspended in 75 pu1 of 0.05 M Tris hydrochloride (pH 8.0)-0.01 M EDTA-25% sucrose containing lysostaphin (1 mg/ml) for staphylococci or lysozyme (20 mg/ml) for enterococci, and incubated at 37°C for 1 h. The resulting protoplasts were lysed by phenol-chloroform extraction, and total DNA was recovered in the supernatant after centrifugation. Portions (5 ,u1) of the crude extracts were denatured for 10 min at 1000C and spotted onto nitrocellulose membranes. Binding of DNA to the filters was done as described previously (25) .
DNA-DNA hybridization. The DNA probes (Table 1) consisted of the 530-bp HpaII fragment of pJH1 (36) for aph3', the 470-bp HpaII fragment of pJH1 (30) for ant6, the 473-bp HinclI fragment of pUB110 (6) for ant4', and the 1,317-bp HincII-TaqI fragment of pIP800 (17) for aph2"-aac6'. DNA fragments cloned in bacteriophage M13mpl8 were hybridized with the 15-bp distal primer and labeled by DNA synthesis in the presence of dGTP, dCTP, dTTP, [a-32P] dATP, and DNA polymerase I (Klenow fragment) (19, 37) . Dot blot hybridization under stringent conditions was done in 50% formamide-5x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate) at 420C for 18 h followed by three washings in 2 x SSC-0. 1% Sarkosyl at room temperature for 15 min and by four washings in 0.2x SSC-0.1% Sarkosyl at 50°C for 15 min.
Assay for aminoglycoside-modifying enzymes. The bacterial extracts were prepared as described previously (14), and the enzymes were assayed by the phosphocellulose paper-binding technique described previously (18) . The final concentration of aminoglycosides in the assay mixture was 66.7 ,ug/ml, and the reaction was allowed to proceed for 30 min at 300C. Enzymes Table 2 for the strains were determined. The values for clinical categorization chosen (Table  2) were based on the study of the distributions of the MICs for a large number of clinical isolates of gram-positive cocci that were susceptible or resistant to aminoglycosides by previously characterized mechanisms (2; Leclercq et al., in press). In this population analysis (R. Bismuth, H. Drugeon, and P. Courvalin, unpublished data), strains that were stochastically distinct from the susceptible population were considered as resistant. The enzyme contents of the strains were then inferred from the resistance phenotype, as indicated in Table 3 and described previously for gram-negative bacteria (32) . Although neomycin is not used in clinical settings, it was included to detect the presence of APH(3') or ANT(4') when it was coresident in the same host with the bifunctional enzyme APH(2")-AAC(6'). In a third step, the correlations between the results of hybridization experiments with specific probes (Table 1 ) and the deduced enzyme contents of the same strains were calculated (Tables 4  to 7 ). Strains representative of the various classes of discrepancies observed were examined by (i) redetermination of MICs of aminoglycosides, (ii) study of the enzyme content of the cells by the phosphocellulose paper-binding assay, and (iii) rehybridization with the set of probes.
Hybridization. (i) ant6 probe. The 6-nucleotidyltransferase modifies streptomycin, and therefore, the corresponding probe could only differentiate strains which were susceptible or resistant to this antibiotic ( Table 4 ). The agreement between the results of hybridization and high-level strepto- b Gentamicin and sisomicin are equivalent, except against E. faecium, because of the chromosomally encoded AAC(6'), which confers resistance to the latter but not to the former antibiotic (27, 38) .
c Phenotypes of antibiotics that are bacteriostatic but not bactericidal are indicated in boldface type.
mycin resistance of the strains was rather low, 80 and 87.6% for staphylococci and enterococci, respectively. Approximately 60 strains of each group of bacteria were resistant to streptomycin and did not hybridize with the probe. The isolates were resistant by production of enzymes other than ANT(6) ( Table 3) or following chromosomal mutation. The latter mechanism confers a very high level of resistance to enterococci (16) , and the MIC of streptomycin for 3 of 10 strains of this group was greater than 100,000 ,ug/ml. More puzzling were the strains, mainly staphylococci, that were streptomycin susceptible but that hybridized with the probe. Curiously, they were all also resistant to kanamycin and structurally related aminoglycosides by production of an APH(3') (see below). Three strains of this group of bacteria were studied further and were not found to produce a streptomycin-modifying enzyme by the phosphocellulose paper-binding assay.
(ii) aph3' probe. Apart from streptomycin, the set of aminoglycosides used in this study could theoretically discriminate five enzymes or enzyme combinations ( Table 3 ). The percentages of agreement obtained with the aph3' probe were extremely high: 99.8 and 100% for staphylococci and enterococci, respectively (Table 5) . Thirty-one staphylococcal strains were considered, on the basis of their resistance phenotype (Table 3) , to encode both APH(2")-AAC(6') and APH(3') but did not hybridize with the probe. All but one hybridized with the aph2"-aac6' and ant4' probes (see below) and therefore do not constitute major errors (Table 1) . This result indicates that neomycin MICs do not allow the discrimination of strains that produce APH(2")-AAC(6') plus APH(3') or ANT(4'). Clinical isolates that harbor these enzyme combinations were therefore assigned to the same group (Tables 5 to 7 ). The remaining discrepancy was a strain of S. aureus which hybridized with the aph2"-aac6' probe and for which the neomycin MIC was 8 ,xg/ml. This isolate was therefore, erroneously, considered as neomycin resistant.
(iii) aph2"-aac6' probe. The agreement observed with the aph2"-aac6' probe (Table 6 ) was identical to that obtained with the aph3' probe. The only discrepancy was an S. aureus strain that hybridized with the probe but that was considered to encode an ANT(4') because the gentamicin MIC for this strain was only 2 ,ug/ml.
(iv) ant4' probe. The agreement obtained with the ant4' probe was 100% for both staphylococci and enterococci (Table 7) . However, in the latter group of organisms, a single strain, E. faecium BM4102 (6), was found to produce an ANT(4').
DISCUSSION
We studied, by dot blot hybridization, the distribution of genes encoding modifying enzymes (Table 1) in ca. 1,000 clinical isolates of gram-positive cocci resistant to aminoglycosides ( Table 2) . As expected, the correlation between streptomycin resistance and hybridization with the probe for the 6-nucleotidyltransferase was rather weak (Table 4) . The low percentages observed (80 and 88%) can be explained, at least in part, by the multiplicity of streptomycin-modifying enzymes (Table 1 ) and the existence of ribosomal mutants (16) . More intriguing is the relatively important number (7%) c Thirty of these strains encoded APH(2`)-AAC(6') plus ANT(4') and therefore do not constitute true discrepancies. of streptomycin-susceptible staphylococci which hybridized with the probe. This type of discrepancy, which was much less frequent (0.5%) in enterococci, could result from the presence in the strains of a silent (26) or remnant ant6 gene or from hybridization to another portion of the genome. The gene for ANT(6) was nearly always (99.8% in staphylococci and 99.6% in enterococci) associated with that encoding an APH(3'). This observation, combined with the fact that the streptomycin-susceptible strains which hybridized with the ant6 probe were all kanamycin resistant, suggests a physical link between the two resistance genes. The agreement obtained between the enzyme content of the strains inferred from aminoglycoside MIC determinations (Table 3) and hybridization with probes internal to the structural genes for APH(3') ( Table 5) , APH(2')-AAC(6') ( Table 6) , and ANT(4') ( Table 7) was excellent.
The probes appeared to be specific, and they did not hybridize with susceptible strains. The results indicate that, as mentioned above, except for streptomycin, modifying enzymes accounted for aminoglycoside resistance in all the clinical isolates that we studied. In fact, one strain of E. faecalis that was resistant to gentamicin by defective uptake of the drug has been reported previously (28) . Strains of E. faecium produce low levels of a chromosomally encoded AAC(6') (27, 38) . The gene for this enzyme did not hybridize with the aph2"-aac6' probe, indicating that the two acetyl- and allows prediction of the bacteriostatic (Table 3 ) and bactericidal activities of the aminoglycosides alone or combined with beta-lactams (Leclercq et al., in press).
The break points for aminoglycoside resistance used in this study (Table 2) were based on the analysis of the distribution of aminoglycoside MICs for a large number of susceptible or resistant strains. There was an excellent correlation, except for amikacin and netilmicin (Table 3) , between the categories they define and the presence or absence of modifying enzymes in the cells; these values may therefore be of clinical relevance. When tested by assays used to evaluate the bacteriostatic activities of antibiotics, the presence of an enzyme confers to the host in vitro resistance to the aminoglycosides that are modified. There are, however, two major exceptions in gram-positive cocci: amikacin and netilmicin (4, 6, 8, 33, 35) . Modification of these drugs by the cells apparently does not affect their bacteriostatic activities (Table 3) . Nevertheless, the bactericidal activities of the two antibiotics and the bactericidal synergy they usually display when combined with betalactams are abolished (R. Bismuth, J. L. Pirault, H. Drugeon, and P. Courvalin, Program Abstr. 29th Intersci. Conf. Antimicrob. Agents Chemother., abstr. no. 705, 1989; Leclercq et al., in press). In vitro determination of the bacteriostatic activities of amikacin and netilmicin is therefore misleading and should not be performed. For the same reasons, assignment of break points for these two aminoglycosides against gram-positive cocci is not possible. Kanamycin instead of amikacin and gentamicin (or sisomicin) instead of netilmicin should be tested. In the case of resistance to kanamycin, amikacin should not be used; in the case of resistance to gentamicin and sisomicin, netilmicin (or amikacin) should not be used (Table 3) .
This study of the prevalence of genes for aminoglycosidemodifying enzymes led to the detection of ANT(4') in Enterococcus spp. (6) , an enzyme that, so far, is confined to staphylococci.
